Theophylline, 70% w/w
| Product | Theophylline, 70% w/w |
| Pharmaceutical Form | Ready to fill pellets |
| Strengths | 60% |
| Release Charecteristics | Sustained Release (like UCB Pharma Inc. – Theo-24 300 mg Capsules) |
| Indications | Treatment of the symptoms and reversible airflow obstruction associated with chronic asthma |
| Posology | Once daily |
| Raw Material | Not available |
| Technical Documents | Technical package available |
| Registration underway | Malaysia |
| Marketing | Egypt, Syria, Belarus |
Description
Ready to fill pellets
